Stock GTBP GT BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs GT Biopharma, Inc.

Equities

GTBP

US36254L3087

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 03:58:36 2024-06-04 pm EDT 		5-day change 1st Jan Change
3.57 USD +0.14% Intraday chart for GT Biopharma, Inc. +1.13% -53.33%
May. 21 Top Midday Decliners MT
May. 21 GT Biopharma Prices $3.2 Million Registered Direct Offering of Shares, Concurrent Private Placement of Warrants MT

Company Profile

GT Biopharma, Inc. specializes in the research and development of therapeutic products used primarily for the treatment of cancer and disorders of the central nervous system. The group has a portfolio of 3 products in clinical development phase (GTB-3550, GTB-3650 and GTB-5550; treatment of leukemia and solid tumors).
Sector
Pharmaceuticals
Calendar
2024-06-25 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
GT BIOPHARMA, INC. Stock GT Biopharma, Inc.
-53.33% 7.69M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+42.83% 748B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.11% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.70% 356B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.06% 325B
ABBVIE INC. Stock AbbVie Inc.
+4.63% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 245B
NOVARTIS AG Stock Novartis AG
+9.26% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-4.21% 209B
PFIZER, INC. Stock Pfizer, Inc.
+2.43% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. GTBP Stock
  4. Funds and ETFs GT Biopharma, Inc.